DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor

• Status: Completed
• Trial end date: 2004-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to find out how well an experimental drug called DepoCyt works for neoplastic meningitis (cancer that has spread to the tissues around the brain and spinal cord). DepoCyt is a new slow-release form of the cancer drug called ara-C (cytarabine). Cytarabine has been used for many years to treat cancer.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pacira Pharmaceuticals, Inc
• Treatments: Cytarabine; Methotrexate

Criteria

• Diagnosed (or previously diagnosed) with lymphoma or a solid tumor (not leukemia)

• Diagnosed with neoplastic meningitis

• If female, not pregnant and will not become pregnant while on-study

• No other experimental therapy within 21 days of participation